What is the recommended dose of adrenaline (epinephrine) for treating anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline Dosing in Anaphylaxis

Administer 0.3-0.5 mg of intramuscular epinephrine (1:1000 concentration) for adults and 0.01 mg/kg (maximum 0.3 mg) for children under 30 kg, injected into the anterolateral thigh, and repeat every 5-15 minutes as needed. 1, 2, 3

Adult Dosing

  • The standard dose is 0.3-0.5 mg of epinephrine (1:1000 concentration) administered intramuscularly into the anterolateral aspect of the thigh. 1, 2, 3
  • Repeat doses every 5-15 minutes based on patient response, with approximately 6-19% of patients requiring a second dose. 1
  • The FDA-approved dosing interval is every 5-10 minutes, though clinical guidelines extend this to 5-15 minutes. 3, 1

Pediatric Dosing

  • For children weighing less than 30 kg (66 lbs), administer 0.01 mg/kg (0.01 mL/kg of 1:1000 concentration) up to a maximum of 0.3 mg intramuscularly. 1, 3
  • For children weighing 30 kg or more, use the adult dose of 0.3-0.5 mg. 3
  • Repeat every 5-10 minutes as necessary. 3

Route of Administration: Critical Considerations

Intramuscular injection into the anterolateral thigh (vastus lateralis muscle) is the only appropriate first-line route. 1, 2

Why IM is Superior:

  • Produces rapid peak plasma concentrations compared to subcutaneous administration. 1
  • Subcutaneous injection has delayed onset of action and is less effective. 4
  • Never inject into buttocks, digits, hands, or feet due to risk of tissue necrosis. 3

When to Consider IV Epinephrine:

  • Reserve intravenous epinephrine exclusively for patients in anaphylactic shock when IV access is already established, or for cardiac arrest/profound hypotension unresponsive to IM epinephrine and fluid resuscitation. 1, 2
  • IV dosing: 0.05-0.1 mg (1:10,000 concentration) administered slowly. 2
  • For continuous infusion: Add 1 mg epinephrine to 1000 mL normal saline, starting at 2 μg/min and titrating up to 10 μg/min based on hemodynamics. 1

Critical Safety Points

There are no absolute contraindications to epinephrine use in anaphylaxis, even in elderly patients with cardiac comorbidities. 1

Common Pitfall to Avoid:

  • Withholding epinephrine due to fear of adverse effects is dangerous and not recommended—the benefits far outweigh the risks. 1
  • Common adverse effects (transient pallor, tremor, anxiety, palpitations) are acceptable given the life-threatening nature of anaphylaxis. 1, 3

Special Populations:

  • Patients on beta-blockers who are unresponsive to epinephrine should receive glucagon: 1-5 mg IV over 5 minutes, followed by infusion of 5-15 μg/min. 2
  • Elderly patients and pregnant women may have increased risk of adverse reactions but should still receive full doses. 3

Timing is Everything

Epinephrine is most effective when given immediately after symptom onset—delays in administration may be fatal. 4, 5

  • Failure to inject epinephrine promptly is a major contributor to anaphylaxis fatalities. 4
  • This is the only medication with life-saving pharmacologic effects across multiple organ systems, preventing and relieving both airway obstruction and shock. 4

References

Guideline

Anaphylaxis Management with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.